Lupin launches Sildenafil inside the United States

Lupin launches Sildenafil inside the United States

by admin- Thursday, September 29th, 2022 03:42:01 PM

Lupin announced the launch of Sildenafil for Oral Suspension, 10 mg/mL, having acquired an approval from the USA Food and Drug Administration (FDA).

Sildenafil for Oral Suspension, 10 mg/mL, is a generic equal of Revatio for Oral Suspension, 10 mg/mL of Viatris Specialty LLC.

Sildenafil for Oral Suspension (RLD Revatio) had estimated annual income of USD sixty four million in the US.

News Updates